Jamie Thomas, DO
Emergency Medicine · Bastrop, TXNPI 1114214962
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 28.6% of the total. Reporting peaked in 2021 at $203 and has fallen 74.2% since, to $52 in 2025. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$154
- Abiomed$113
- Novo Nordisk$76
- Pfizer$50
- Lilly USA, LLC$29
- Amgen$28
- plus $87 from 5 others
What the payments were for
- Food & beverage$538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $154 |
| Abiomed | 2 | $113 |
| Novo Nordisk | 3 | $76 |
| Pfizer | 3 | $50 |
| Lilly USA, LLC | 2 | $29 |
| Amgen | 2 | $28 |
| GSK | 2 | $22 |
| Abbott | 1 | $21 |
| Apria Healthcare LLC | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| AstraZeneca | 1 | $11 |
How this compares
$538 in reported general payments places this provider in the 90th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $785 |
| Ondansetron OdtOndansetron | 45 | $563 |
| Pantoprazole Sodium | 16 | $544 |
| Doxycycline Hyclate | 48 | $430 |
| Montelukast Sodium | 13 | $337 |
| Sucralfate | 12 | $299 |
| Clindamycin Hcl | 20 | $294 |
| Fluoxetine Hcl | 12 | $278 |
| Potassium Chloride | 28 | $248 |
| Atorvastatin Calcium | 16 | $246 |
| Cephalexin | 50 | $230 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $189 |
| Prednisone | 98 | $136 |
| Furosemide | 22 | $124 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Bastrop
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
- Myiesha TaylorSunnyvale$369K
- James WilliamsSan Antonio$360K
- Armando MolinaEl Paso$290K
- Arthur AbelloAustin$204K
- Farid DharamsiDallas$159K
- David RobinsonHouston$143K
- Basil KhalafHouston$93K
- Elizabeth FaganMcKinney$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.